“…In addition to the potential for recombination events, we also evaluated potential associations between identified mutations and the severity of disease in the patient. Studies suggested that missense mutations could be related to the virus’s ongoing adaptation, reduced symptoms, or disease severity, along with changes in other characteristics such as transmission rates [ 28 , 29 ]. Therefore, we examined the impacts of frequencies of silent and missense mutations on four groups of variants and patient outcomes: Omicron-ICU (group A), Omicron-not-ICU (group B), Delta-ICU (group C), and Delta-not-ICU (group D) ( Supplemental Figure S3 , Supplemental Table S4 ).…”